Cost-effectiveness of second-line vasopressors for the treatment of septic shock.

We determine the cost-effectiveness of escalating doses of norepinephrine or norepinephrine plus the adjunctive use of vasopressin or angiotensin II as a second-line vasopressor for septic shock. Vasopressin is the most cost-effective second-line vasopressor in both the short- and long-term evaluations. Vasopressor price is a minor contributor to overall cost.

Source: Current Awareness Service for Health (CASH) - January 3, 2020 Category: Consumer Health News Source Type: news